Trupti N Patel

@vit.ac.in

Professor & Head, Department of Integrative Biology
VIT, Vellore

Trupti N Patel
Highly motivated Cancer Biologist and an Academician with a drive to conduct superior research and inspire people to pursue personal and professional excellence. Academically engaged in generating skilled and perennial learners by stimulating creative learning environment while being committed to pursuing and achieving outstanding research milestones. Over 25 years of teaching and research experience and associations with global scientific community.

EDUCATION

PhD (Life Sciences) Submitted - December 2000
Defended - June 2001
Awarded - March 2002
Title of Research – “Ameliorative effects of some antidotes on Aluminum chloride and Sodium fluoride toxicity in female mammals”
Duties and Responsibilities - June 1996-May 2001 under Sir Dorabji Tata Scholarship - Research: School of Sciences, Dept. of Zoology-Gujarat University - Toxicology and Genotoxicity; Cytogenetic Diagnostics and Counseling at UGC-COSIST Sponsored Human Cytogenetics Clinic; Academic: Assisting Laboratory Classes in Cytogenetics, Physiology, Biochemistry and Biomedical Science.

RESEARCH, TEACHING, or OTHER INTERESTS

Cancer Research, Toxicology, Molecular Biology, Multidisciplinary

FUTURE PROJECTS

Microsatellite instability across various tumor types: diagnostic criteria, methods of detection and bio-clinical associations

Microsatellite instability (MSI) is a specific molecular tumor phenotype recognized by accumulation of mutations in microsatellites. Microsatellites are repetitive DNA sequences consisting of 1-6 nucleotides. MSI is caused by defective DNA mismatch repair, resulting from hereditary or somatic mutations in the MLH1, MSH2, MSH6, PMS2 genes or hypermethylation of the MLH1 promoter. MSI is most often observed in the uterine cancer (≈ 30%), gastric cancer (≈ 20%), colon cancer (≈ 15%) and rectal carcinomas (≈ 6%) and is much less common in other tumor types. MSI testing has become particularly relevant after the establishment of the predictive role of MSI for the efficacy of immune checkpoint inhibitors, one of the most promising and widely used therapeutic agents in oncology today.


Applications Invited
DNA Diagnostics
51

Scopus Publications

Scopus Publications